Chemical modifications of phospholipases A2 from snake venoms: Effects on catalytic and pharmacological properties

Toxicon

Volumn 42, Issue 8, 2003, Pages 855-868

  Soares, Andreimar M ^a   Giglio, José R ^b  

^a UNIVERSITY OF RIBEIRÃO PRETO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chemical modification; Myotoxin; Phospholipase A2; Snake venom

Indexed keywords

HISTIDINE; LYSINE; METHIONINE; OCTAPEPTIDE; PHOSPHOLIPASE A2; SNAKE VENOM;

AMINO TERMINAL SEQUENCE; CHEMICAL MODIFICATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME STRUCTURE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN ISOLATION; REVIEW; TOXICITY;

SERPENTES;

EID: 1042287118     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2003.11.004     Document Type: Article

References (123)

1. Abe T., Alema S., Miledi R. Isolation and characterization of presynaptically acting neurotoxins from the venom of Bungarus snakes. Eur. J. Biochem. 80:1977;1-12.
2. 2 in Bothrops snake venoms: effects of chemical modifications on the enzymatic and pharmacological properties of Bothropstoxins from Bothrops jararacussu. Biochimie. 82:2000;755-763.
3. 2 from Bothrops jararacussu snake venom. Biochem. Pharmacol. 64:2002;723-732.
4. 2 from Bothrops asper snake venom. Toxicon. 39:2001;879-887.
5. 2 - a structural review. Toxicon. 34:1996;827-841.
6. 2 from Naja naja naja and Vipera russelli snake venoms. Toxicon. 29:1991;1251-1262.
7. 2 from Vipera russelli snake venom by guanidination of lysine residues. Toxicon. 32:1994;749-752.
8. 2. Annu. Rev. Pharmacol. Toxicol. 39:1999;175-189.
9. 2. Toxicon. 22:1984;743-758.
10. Biondo R., Pereira A.M.S., Marcussi S., Pereira P.S., França S.C., Soares A.M. Inhibition of enzymatic and pharmacological activities of some snake venoms and toxins by Mandevilla velutina (Apocynaceae) aqueous extract. Biochimie. 85:2003;. (in press).
11. Blackwell G.J., Flower R.J. Inhibition of phospholipase. Br. Med. Bull. 39:1983;260-264.
12. 2, on liposomes and mouse gastrocnemius muscle. Toxicon. 31:1993;217-222.
13. 2 isolated from Bothrops asper (Terciopelo) venom. Biochim. Biophys. Acta. 1179:1993;253-259.
14. 2 from Bungarus multicinctus (Taiwan banded krait) snake venom. J. Protein Chem. 13:1994;641-648.
15. 2. J. Biochem. (Tokyo). 124:1998;764-768.
16. 2 isolated from the venom of the snake Bothrops asper (terciopelo). Toxicon. 36:1998;1861-1869.
17. 2+ complex-formation. Biochem. J. 278:1991;481-486.
18. 2-independent neurotoxic effect. Biochem. J. 295:1993;713-718.
19. 2 from cobra venom with cytotoxic properties not related to esterase activity. Purification, amino acid sequence, and biological properties. J. Biol. Chem. 264:1989;13289-13297.
20. 2 from snake venom are unrelated. FEBS Lett. 248:1989;1-4.
21. Cintra A.C.O., Marangoni S., Oliveira B., Giglio J.R. Bothropstoxin-I: amino acid sequence and function. J. Protein Chem. 12:1993;57-64.
22. 2-induced oedema in rat paw. Eur. J. Pharmacol. 166:1989;505-510.
23. 2 from Hemachatus haemachatus and Naja naja atra venoms. Toxicon. 19:1981;61-71.
24. 2. Toxicon. 19:1981;705-720.
25. 2 on enzymatic activity, lethality and anticoagulant action. Toxicon. 19:1981;721-725.
26. 2. Life Sci. 32:1983;1455-1461.
27. 2: effects on enzymatic activity, lethality and some pharmacological properties. Toxicon. 21:1983;209-218.
28. 2. Can. J. Physiol. Pharmacol. 63:1985;331-339.
29. 2 with micellar interfaces. The role of the N-terminal region. Biochemistry. 14:1975;5387-5394.
30. 2, anticoagulant and myotoxic activities. Biochim. Biophys. Acta. 1070:1991;455-460.
31. 2, affects its pharmacological activities. Toxicon. 31:1993;1202-1206.
32. 2, reduces its membrane-destabilizing effect. Arch. Biochem. Biophys. 312:1994;336-339.
33. 2 isolated from Bothrops asper and Bothrops godmani snake venoms: effects on enzymatic and pharmacological properties. Toxicon. 35:1997;241-252.
34. 2 engineering. Structural and functional roles of highly conserved active site residues tyrosine-52 and tyrosine-73. Biochemistry. 31:1992;6402-6413.
35. 2 from Naja melanoleuca snake venom. Eur. J. Biochem. 132:1983;177-182.
36. van Eijk J.H., Verheij H.M., de Haas G.H. Characterization of phospholipases A2 of Naja melanoleuca snake venom modified at the N-terminal region. Eur. J. Biochem. 139:1984;51-57.
37. 2. Biochimie. 82:2000;833-840.
38. 2. Arch. Biochem. Biophys. 284:1991;352-359.
39. 2 isolated from Lachesis muta (Bushmaster) snake venom. Thromb. Haemost. 78:1997;1372-1380.
40. 2 isolated from Lachesis muta (Bushmaster) snake venom. Toxicon. 38:2000;961-972.
41. 2 isolated from Lachesis muta snake venom. Comparison with lysophosphatidylcholine. Int. J. Biochem. Cell Biol. 35:2003;1470-1481.
42. 2 myotoxins from Bothrops snake venoms. Toxicon. 33:1995;1405-1424.
43. 2 Enzymes: Structure, Function and Mechanism. 1997;321-352 Wiley, Chichester.
44. Halliwell J.V., Tse C.K., Spokes J.W., Othman I., Dolly J.O. Biochemical and electrophysiological demonstrations of the actions of beta-bungarotoxin on synapses in brain. J. Neurochem. 39:1982;543-550.
45. Halpert J., Eaker D., Karlsson E. The role of phospholipase activity in the action of a presynaptic neurotoxin from the venom of Notechis scutatus scutatus (Australian tiger snake). FEBS Lett. 61:1976;72-76.
46. 2. Toxicon. 24:1986;337-345.
47. Homsi-Brandeburgo M.I., Queiroz L.S., Santo-Neto H., Rodrigues-Simioni L., Giglio J.R. Fractionation of Bothrops jararacussu snake venom: partial chemical characterization and biological activity of bothropstoxin. Toxicon. 26:1988;615-627.
48. Kaiser I.I., Gutiérrez J.M., Plummer D., Aird S.D., Odell G.V. The amino acid sequence of a myotoxic phospholipase from the venom of Bothrops asper. Arch. Biochem. Biophys. 278:1990;319-325.
49. Karlsson E., Pongsawasdi P. Purification of two phospholipase A isoenzymes with anticoagulant activity from the venom of the cobra Naja naja siamensis. Toxicon. 18:1980;409-419.
50. 2 Enzymes: Structure, Function and Mechanism. 1997;1-28 Wiley, Chichester.
51. 2. Toxicon. 27:1989;613-635.
52. Kondo K., Toda H., Narita K. Characterization of phospholipase A activity of beta1-bungarotoxin from Bungarus multicinctus venom. II. Identification of the histidine residue of beta1-bungarotoxin modified by p-bromophenacyl bromide. J. Biochem. (Tokyo). 84:1978;1301-1308.
53. 2. Protein Engng. 4:1990;199-204.
54. 2 homologues: dissociation between enzymatic and biological activities. Eur. J. Pharmacol. 343:1998;257-263.
55. Liao T.H., Ting R.S., Yeung J.E. Reactivity of tyrosine in bovine pancreatic deoxyribonuclease with p-nitrobenzenesulfonyl fluoride. J. Biol. Chem. 257:1982;5637-5644.
56. 2 myotoxin isoforms from Bothrops asper. Int. J. Biochem. Cell Biol. 33:2001;127-132.
57. 2 expresses enhanced membrane-damaging activities and reproduces its in vivo myotoxic effect. Biochim. Biophys. Acta. 1461:1999;19-26.
58. 2 myotoxins. Toxicon. 37:1999;199-215.
59. 2 and their zymogens. Biochemistry. 18:1979;3589-3597.
60. 2 from Trimeresurus flavoviridis. J. Biochem. (Tokyo). 105:1989;565-572.
61. Mollier P., Chwetzoff S., Bouet F., Harvey A.L., Ménez A. Tryptophan 110, a residue involved in the toxic activity but not in the enzymatic activity of notexin. Eur. J. Biochem. 185:1989;263-270.
62. 2. J. Biochem. (Tokyo). 131:2002;285-292.
63. 2. Proc. Natl Acad. Sci. USA. 77:1980;1346-1350.
64. 2 from Bothrops alternatus (vibora de la cruz) venom. Toxicon. 26:1988;1137-1144.
65. 2 and its N-terminal octapeptide-removed and p-bromophenacylated derivatives with acridine and anilinonaphthalene dyes. J. Biochem (Tokyo). 100:1986;1551-1560.
66. Ownby C.L. Structure, function and biophysical aspects of the myotoxins from snake venoms. J. Toxicol.-Toxin Rev. 17:1998;213-238.
67. 2 myotoxin from the venom of the prairie rattlesnake (Crotalus viridis viridis). Toxicon. 35:1997;111-124.
68. 2 proteins. Toxicon. 37:1999;411-445.
69. 2 activity. J. Protein Chem. 17:1998;381-386.
70. 2. Biochemistry. 13:1974;1455-1460.
71. 2 from bovine pancreas and Crotalus atrox venom. J. Biol. Chem. 260:1985;11627-11634.
72. 2 covalently inhibited by p-bromo-phenacyl-bromide. J. Biol. Chem. 200:1988;181-188.
73. 2 (Naja naja naja). A case of half-site reactivity. J. Biol. Chem. 252:1977;2405-2411.
74. Rodrigues V.M., Soares A.M., Mancin A.C., Fontes M.R.M., Homsi-Brandeburgo M.I., Giglio J.R. Geographic variations in the composition of myotoxins from Bothrops neuwiedi snake venoms: biochemical characterization and biological activity. Comp. Biochem. Physiol. 121A:1998;215-222.
75. Rosenberg P. The relationship between enzymatic activity and pharmacological properties of phospholipases in natural poisons. Harris J.B. Animal, Plant and Microbial Toxins. 1986;129-140 Oxford University Press, Oxford.
76. Rosenberg P. Phospholipases. Shier W.T., Mebs D. Handbook of Toxinology. 1989;67-277 Marcel Dekker, New York.
77. 2 Enzymes: Structure, Function and Mechanism. 1997;155-184 Wiley, Chichester.
78. 2 by modification of carboxylate groups. Biochem. Pharmacol. 32:1983;3525-3530.
79. Rosenberg P., Ghassemi A., Condrea E., Dhillon D., Yang C.C. Do chemical modifications dissociate between the enzymatic and pharmacological activities of beta bungarotoxin and notexin? Toxicon. 27:1989;137-159.
80. Rufini S., Cesaroni P., Desideri A., Farias R., Gubensek F., Gutiérrez J.M., Luly P., Massoud R., Morero R., Pedersen J.Z. Calcium ion independent membrane leakage induced by phospholipase-like myotoxins. Biochemistry. 31:1992;12424-12430.
81. Salach J.I., Seng R., Tisdale H., Singer T.P. Phospholipase A of snake venoms. II. Catalytic properties of the enzyme from Naja naja. J. Biol. Chem. 246:1971;340-347.
82. 2. Science. 250:1990;1541-1546.
83. 2 from the venom of Agkistrodon piscivorus piscivorus. J. Biol. Chem. 267:1992;22645-22657.
84. 2, from the venom of the snake Bothrops jararaca: purification, primary structure analysis, and its characterization as a platelet-aggregation- inhibiting factor. Arch. Biochem. Biophys. 367:1999;26-32.
85. 2 enzymes: classification and characterization. Biochim. Biophys. Acta. 1488:2000;1-19.
86. Soares A.M., Rodrigues V.M., Homsi-Brandeburgo M.I., Toyama M.H., Lombardi F.R., Arni R.K., Giglio J.R. A rapid procedure for the isolation of the Lys-49 myotoxin II from Bothrops moojeni (caissaca) venom: biochemical characterization, crystallization, myotoxic and edematogenic activity. Toxicon. 36:1998;503-514.
87. Soares A.M., Andrião-Escarso S.H., Angulo Y., Lomonte B., Gutiérrez J.M., Marangoni S., Toyama M.H., Arni R.K., Giglio J.R. Structural and functional characterization of a myotoxin I from Bothrops moojeni (caissaca) snake venom. Arch. Biochem. Biophys. 373:2000;7-15.
88. 2 homologue, from Bothrops neuwiedi pauloensis venom. Arch. Biochem. Biophys. 378:2000;201-209.
89. 2 subunit of crotoxin from Crotalus durissus terrificus snake venom, on its enzymatic and pharmacological activities. Int. J. Biochem. Cell Biol. 33:2001;877-888.
90. 2 from Bothrops pirajai snake venom. Arch. Biochem. Biophys. 387:2001;188-196.
91. 2 myotoxin inhibitor protein from Bothrops moojeni snake plasma. Biochem. Biophys. Res. Commun. 302:2003;193-200.
92. 2 in Bothrops moojeni venom: a promising approach to an enhanced antivenom production. Int. J. Biochem. Cell Biol. 36:2004;258-270.
93. 2 from Naja nigricollis and Naja naja atra snake venoms. Toxicon. 24:1986;670-693.
94. 2 from the venom of Australian king brown snake, on its biological activities. Toxicon. 28:1990;107-117.
95. 2 in which the alpha-amino group is modified to an alpha-keto group. J. Biochem. (Tokyo). 96:1913;1903-1903.
96. 2 and their pathophysiological significance in inflammatory diseases. Curr. Mol. Med. 1:2001;739-754.
97. Toyama M.H., Soares A.M., Vieira C.A., Novello J.C., Oliveira B., Giglio J.R., Marangoni S. Amino acid sequence of piratoxin-I, a myotoxin from Bothrops pirajai snake venom and its biological activity after alkylation with p-bromophenacyl bromide. J. Protein Chem. 17:1998;713-718.
98. 2 and anticoagulant activities and high myotoxic activity. J. Protein Chem. 18:1999;371-378.
99. 2 homologue from Bothrops pirajai venom. Biochimie. 82:2000;245-250.
100. Trento E.P., Garcia O.S., Rucavado A., França S.C., Batalini C., Arantes E.C., Giglio J.R., Soares A.M. Inhibitory properties of anti-bothropic complex from Didelphis albiventris serum on toxic and pharmacological actions of metalloproteases and myotoxins from Bothrops asper venom. Biochem. Pharmacol. 62:2001;1521-1529.
101. 2 from Callosellasma rhodostoma venom gland: cloning and sequencing of 10 of the cDNAs, three-dimensional modelling and chemical modification of the major isozyme. Eur. J. Biochem. 267:2000;6684-6691.
102. 2. Role of histidine and calcium ion in the catalytic mechanism. Biochemistry. 19:1980;743-750.
103. 2. Rev. Physiol. Biochem. Pharmacol. 91:1981;91-203.
104. 2 from the venom of Bitis gabonica. Biochim. Biophys. Acta. 483:1977;107-120.
105. 2. Biochemistry. 13:1974;1446-1454.
106. 2 enzymes. Eur. J. Pharmacol. 190:1990;347-354.
107. 2. Protein Engng. 11:1998;285-294.
108. 2. Toxicon. 36:1998;1623-1633.
109. 2 in a complex with a transition-state analogue. Science. 250:1990;1560-1563.
110. 2. Biochimie. 70:1988;1215-1222.
111. 2 from snake venoms. J. Toxicol. 13:1994;125-177.
112. 2 Enzymes: Structure, Function and Mechanism. 1997;185-204 Wiley, Chichester.
113. 2 from Naja naja atra (Taiwan cobra) and Naja nigricollis (spitting cobra) venoms. Toxicon. 26:1988;721-731.
114. 2 from Naja naja atra (Taiwan cobra) snake venom. Biochem. J. 262:1989;855-860.
115. Yang C.C., Chang L.S. Dissociation of lethal toxicity and enzymic activity of notexin from Notechis scutatus scutatus (Australian-tiger-snake) venom by modification of tyrosine residues. Biochem. J. 280:1991;739-744.
116. 2 from the venom of Naja nigricollis. Biochim. Biophys. Acta. 614:1980;373-380.
117. 2 from the Hemachatus haemachatus snake venom. Toxicon. 18:1980;529-547.
118. 2 from the venom of Naja naja atra (Taiwan cobra). Toxicon. 19:1981;645-659.
119. 2. Toxicon. 21:1983;509-512.
120. 2 from Naja naja atra and Naja nigricollis snake venoms. J. Protein Chem. 4:1985;87-94.
121. 2 using polyclonal and monoclonal antibodies. Toxicon. 30:1992;151-159.
122. 2 modified by p-bromo-phenacyl-bromide. Toxicon. 36:1998;875-886.
123. 2 blocks malaria parasite development in the mosquito midgut by inhibiting ookinete association with the midgut surface. J. Exp. Biol. 204:2001;4157-4161.